Skip to content

Clinical trials

Phase 1/2 Hearing Loss, Sensorineural trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hearing Loss, Sensorineural Phase: Phase 1/2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20151
20181
20191
20202
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Unknown status2
Not yet recruiting1
Active, not recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Andrea Vambutas1
Contineum Therapeutics1
Frequency Therapeutics1
James Baumgartner, MD1
Khon Kaen University1
Neuracle Science Co., LTD.1
Nordmark Arzneimittel GmbH & Co. KG1
Otonomy, Inc.1
Regeneron Pharmaceuticals1
Rinri Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hearing Loss, Sensorineural15
Hearing Loss8
Deafness5
Hearing Disorders4
Hearing Loss, Hidden4
Ear Diseases3
Hearing Loss, Sudden3
Hearing Loss, Bilateral2
Presbycusis2
Auditory Diseases, Central1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.